John Carney covers Wall Street and finance for CNBC.com, where he runs NetNet, the go-to blog to get the low-down and the high jinks of Wall Street.
Carney joined CNBC in 2010 after serving as managing editor of Business Insider's Wall Street and economics section. Prior to that he was editor in chief of DealBreaker.com, a Wall Street online tabloid.
His writing has appeared in The Wall Street Journal, The New York Times, The New York Sun, Page Six Magazine, the New York Post, Fortune, Gawker and New York magazine.
He is a frequent guest on CNBC's "Power Lunch" and public radio′s "Marketplace." His writing often takes controversial positions on business topics. He has argued, for example, that failed banks should not be bailed out, that Lehman′s collapse was not a disaster and that insider trading should be legal.
Carney received a law degree from the University of Pennsylvania and practiced corporate law at firms such as Skadden, Arps, Slate, Meagher & Flom and Latham & Watkins. He primarily represented banks, hedge funds and private equity firms.
Follow John Carney on Twitter @Carney.
The bank has radically redefined itself in the wake of the global financial crisis.
In the hedge fund world, the rich are getting richer — but barely.
Investors are slowly coming to grips with a summertime Fed rate hike, but the timing could get interesting.
This NY-based boutique bank will score a monster payday if the $62B Bayer-Monsanto deal goes through.